中国卫生产业
中國衛生產業
중국위생산업
CHINA HEALTH INDUSTRY
2012年
36期
166
,共1页
西酞普兰%氯氮平%自杀风险%精神分裂症
西酞普蘭%氯氮平%自殺風險%精神分裂癥
서태보란%록담평%자살풍험%정신분렬증
Citalopram%Clozapine%Schizophrenia%Suicidal Risk
[要]?本文通过46例有自杀风险的精神分裂症患者随机分为研究组(23例)和对照组(23例)探讨西酞普兰合并氯氮平治疗有自杀风险的精神分裂症患者的疗效及安全性.验证了西酞普兰合并氯氮平治疗有自杀风险的精神分裂症患者的疗效好于单用氯氮平,自杀风险降低,安全性相仿.
[要]?本文通過46例有自殺風險的精神分裂癥患者隨機分為研究組(23例)和對照組(23例)探討西酞普蘭閤併氯氮平治療有自殺風險的精神分裂癥患者的療效及安全性.驗證瞭西酞普蘭閤併氯氮平治療有自殺風險的精神分裂癥患者的療效好于單用氯氮平,自殺風險降低,安全性相倣.
[요]?본문통과46례유자살풍험적정신분렬증환자수궤분위연구조(23례)화대조조(23례)탐토서태보란합병록담평치료유자살풍험적정신분렬증환자적료효급안전성.험증료서태보란합병록담평치료유자살풍험적정신분렬증환자적료효호우단용록담평,자살풍험강저,안전성상방.
To research the efficacy and safety of combined citalopram and clozapine in the treatment of schizophrenia with suicidal risk,A study was contucted in which 46 patients with schizophrenia were randomised divided to study group and control group.The result shows that the efficacy of treatment of Combined Citalopram and Clozapine is better than treatment of Clozapine. the risk of suicide also cecreace by Combined Citalopram and Clozapine.and the safety is equivalent.